Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac

Magnus Nakrem Lyngbakken1,2, Erika Nerdrum Aagaard1,2, Brede Kvisvik1,2

  • 1Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.

Clinical Chemistry
|April 1, 2020
PubMed

Insights

Cardiac troponin I (cTnI) and T (cTnT) levels indicate different cardiovascular risks. cTnI better predicts subclinical left ventricular hypertrophy than cTnT in the general population.

Area of Science:

  • Cardiology
  • Biomarkers
  • Cardiovascular Disease

Background:

  • Cardiac troponin I (cTnI) and T (cTnT) correlate with cardiac outcomes but not closely in the general population.
  • Hypothesized that cTnI and cTnT are influenced by different cardiovascular (CV) and non-CV risk factors, reflecting distinct CV phenotypes.

Purpose of the Study:

  • To investigate the differential associations of cTnI and cTnT with CV and non-CV risk factors.
  • To determine the relationship between cTnI, cTnT, and subclinical cardiovascular disease, particularly left ventricular hypertrophy and dysfunction.

Main Methods:

  • Prospective observational study of 1236 women and 1157 men from the Akershus Cardiac Examination 1950 Study.
  • Measured cTnI and cTnT using last-generation assays in individuals without known CV disease.
  • Extensive CV phenotyping, including detailed echocardiography, was performed at baseline.

Main Results:

  • cTnI was measurable in 60.3% and cTnT in 72.5% of participants; moderate correlation (r=0.53).
  • cTnI associated with male sex, higher education, hypertension, and age; cTnT associated with eGFR.
  • Both troponins inversely associated with global longitudinal strain and positively with LV mass index (LVMI); cTnI association with LVMI was stronger.
  • cTnI improved diagnostic accuracy for LV hypertrophy, while cTnT did not.

Conclusions:

  • cTnI and cTnT concentrations are linked to subclinical LV hypertrophy and dysfunction in a community-based cohort.
  • cTnI demonstrates superior predictive value for subclinical left ventricular hypertrophy compared to cTnT.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
150
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
301
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
363
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
203
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
242